HEADER BLOOD CLOTTING 17-MAR-11 3R4L TITLE HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 CAVEAT 3R4L NAG B 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMINOGEN ACTIVATOR INHIBITOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 24-402; COMPND 5 SYNONYM: PAI, PAI-1, ENDOTHELIAL PLASMINOGEN ACTIVATOR INHIBITOR, COMPND 6 SERPIN E1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: ACTIVE FORM SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PAI1, PLANH1, SERPINE1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS SERINE PROTEASE INHIBITOR, PAI-1, VERY LONG HALF LIFE, PLASMINOGEN KEYWDS 2 ACTIVATOR INHIBITOR TYPE 1, CARBOHYDRATE, BLOOD CLOTTING EXPDTA X-RAY DIFFRACTION AUTHOR J.YANG,H.ZHENG,Q.HAN,E.SKRZYPCZAK-JANKUN,J.JANKUN REVDAT 3 29-JUL-20 3R4L 1 CAVEAT COMPND REMARK SEQADV REVDAT 3 2 1 HET HETNAM FORMUL LINK REVDAT 3 3 1 SITE ATOM REVDAT 2 08-NOV-17 3R4L 1 REMARK REVDAT 1 02-NOV-11 3R4L 0 JRNL AUTH J.JANKUN,J.YANG,H.ZHENG,F.Q.HAN,A.AL-SENAIDY, JRNL AUTH 2 E.SKRZYPCZAK-JANKUN JRNL TITL REMARKABLE EXTENSION OF PAI-1 HALF-LIFE SURPRISINGLY BRINGS JRNL TITL 2 NO CHANGES TO ITS STRUCTURE. JRNL REF INT.J.MOL.MED. V. 29 61 2012 JRNL REFN ISSN 1107-3756 JRNL PMID 21947232 JRNL DOI 10.3892/IJMM.2011.798 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.CHOROSTOWSKA-WYNIMKO,R.SWIERCZ,E.SKRZYPCZAK-JANKUN, REMARK 1 AUTH 2 A.WOJTOWICZ,S.H.SELMAN,J.JANKUN REMARK 1 TITL A NOVEL FORM OF THE PLASMINOGEN ACTIVATOR INHIBITOR CREATED REMARK 1 TITL 2 BY CYSTEINE MUTATIONS EXTENDS ITS HALF-LIFE: RELEVANCE TO REMARK 1 TITL 3 CANCER AND ANGIOGENESIS. REMARK 1 REF MOL.CANCER THER. V. 2 19 2003 REMARK 1 REFN ISSN 1535-7163 REMARK 1 PMID 12533669 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.JANKUN,A.M.ALEEM,S.H.SELMAN,V.BASRUR,E.SKRZYPCZAK-JANKUN REMARK 1 TITL VLHL PLASMINOGEN ACTIVATOR INHIBITOR SPONTANEOUSLY REMARK 1 TITL 2 REACTIVATES FROM THE LATENT TO ACTIVE FORM. REMARK 1 REF INT.J.MOL.MED. V. 23 57 2009 REMARK 1 REFN ISSN 1107-3756 REMARK 1 PMID 19082507 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0093 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 81.8 REMARK 3 NUMBER OF REFLECTIONS : 13038 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 709 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1014 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.42 REMARK 3 BIN R VALUE (WORKING SET) : 0.3030 REMARK 3 BIN FREE R VALUE SET COUNT : 53 REMARK 3 BIN FREE R VALUE : 0.3670 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2995 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 74 REMARK 3 SOLVENT ATOMS : 17 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 68.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.73000 REMARK 3 B22 (A**2) : 3.73000 REMARK 3 B33 (A**2) : -5.60000 REMARK 3 B12 (A**2) : 1.87000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.367 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.408 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.310 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.309 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3149 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4281 ; 1.860 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 376 ; 8.148 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 138 ;36.098 ;23.841 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 526 ;21.882 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;23.120 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 496 ; 0.126 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2343 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3R4L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000064481. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : ASYMMETRIC CURVED CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13852 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.699 REMARK 200 RESOLUTION RANGE LOW (A) : 33.003 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.4 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.27000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 9PAI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.025M NACL, 27% TERT-BUTANOL, 0.050M REMARK 280 TRIS-HCL, PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.82700 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 129.65400 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 129.65400 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 64.82700 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 24 REMARK 465 HIS A 25 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 51 126.87 -28.25 REMARK 500 ASP A 91 170.30 -58.60 REMARK 500 LYS A 127 109.89 -56.07 REMARK 500 MET A 133 -70.92 -39.83 REMARK 500 ARG A 141 -179.81 51.43 REMARK 500 SER A 142 171.71 54.50 REMARK 500 VAL A 152 -125.17 30.10 REMARK 500 SER A 172 -94.23 -88.18 REMARK 500 ASN A 173 40.18 -85.61 REMARK 500 LYS A 177 -35.20 -32.42 REMARK 500 VAL A 180 120.41 121.21 REMARK 500 GLN A 182 -31.12 -37.69 REMARK 500 SER A 206 32.25 -97.75 REMARK 500 LYS A 214 171.16 -55.08 REMARK 500 ASP A 216 12.57 -67.94 REMARK 500 SER A 218 -176.25 -58.43 REMARK 500 GLN A 326 -39.84 -154.09 REMARK 500 GLU A 336 -84.54 -15.79 REMARK 500 ASN A 352 82.32 -170.27 REMARK 500 GLU A 353 -55.58 80.06 REMARK 500 VAL A 357 70.33 -57.58 REMARK 500 ALA A 358 -8.79 48.18 REMARK 500 VAL A 364 138.67 -37.51 REMARK 500 VAL A 366 50.43 -101.79 REMARK 500 ALA A 368 -125.57 -79.58 REMARK 500 ALA A 371 105.86 -1.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 336 PRO A 337 -142.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3Q02 RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE REMARK 900 CONFORMATION, MUTANT W175F REMARK 900 RELATED ID: 1DVM RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR INHIBITOR-1, ACTIVE, MUTANT N150H, K154T, REMARK 900 Q319L, M354I REMARK 900 RELATED ID: 1B3K RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR INHIBITOR-1, ACTIVE, MUTANT N150H, K154T, REMARK 900 Q319L, M354I DBREF 3R4L A 24 402 UNP P05121 PAI1_HUMAN 24 402 SEQADV 3R4L CYS A 197 UNP P05121 GLN 197 ENGINEERED MUTATION SEQADV 3R4L CYS A 355 UNP P05121 GLY 355 ENGINEERED MUTATION SEQRES 1 A 379 VAL HIS HIS PRO PRO SER TYR VAL ALA HIS LEU ALA SER SEQRES 2 A 379 ASP PHE GLY VAL ARG VAL PHE GLN GLN VAL ALA GLN ALA SEQRES 3 A 379 SER LYS ASP ARG ASN VAL VAL PHE SER PRO TYR GLY VAL SEQRES 4 A 379 ALA SER VAL LEU ALA MET LEU GLN LEU THR THR GLY GLY SEQRES 5 A 379 GLU THR GLN GLN GLN ILE GLN ALA ALA MET GLY PHE LYS SEQRES 6 A 379 ILE ASP ASP LYS GLY MET ALA PRO ALA LEU ARG HIS LEU SEQRES 7 A 379 TYR LYS GLU LEU MET GLY PRO TRP ASN LYS ASP GLU ILE SEQRES 8 A 379 SER THR THR ASP ALA ILE PHE VAL GLN ARG ASP LEU LYS SEQRES 9 A 379 LEU VAL GLN GLY PHE MET PRO HIS PHE PHE ARG LEU PHE SEQRES 10 A 379 ARG SER THR VAL LYS GLN VAL ASP PHE SER GLU VAL GLU SEQRES 11 A 379 ARG ALA ARG PHE ILE ILE ASN ASP TRP VAL LYS THR HIS SEQRES 12 A 379 THR LYS GLY MET ILE SER ASN LEU LEU GLY LYS GLY ALA SEQRES 13 A 379 VAL ASP GLN LEU THR ARG LEU VAL LEU VAL ASN ALA LEU SEQRES 14 A 379 TYR PHE ASN GLY CYS TRP LYS THR PRO PHE PRO ASP SER SEQRES 15 A 379 SER THR HIS ARG ARG LEU PHE HIS LYS SER ASP GLY SER SEQRES 16 A 379 THR VAL SER VAL PRO MET MET ALA GLN THR ASN LYS PHE SEQRES 17 A 379 ASN TYR THR GLU PHE THR THR PRO ASP GLY HIS TYR TYR SEQRES 18 A 379 ASP ILE LEU GLU LEU PRO TYR HIS GLY ASP THR LEU SER SEQRES 19 A 379 MET PHE ILE ALA ALA PRO TYR GLU LYS GLU VAL PRO LEU SEQRES 20 A 379 SER ALA LEU THR ASN ILE LEU SER ALA GLN LEU ILE SER SEQRES 21 A 379 HIS TRP LYS GLY ASN MET THR ARG LEU PRO ARG LEU LEU SEQRES 22 A 379 VAL LEU PRO LYS PHE SER LEU GLU THR GLU VAL ASP LEU SEQRES 23 A 379 ARG LYS PRO LEU GLU ASN LEU GLY MET THR ASP MET PHE SEQRES 24 A 379 ARG GLN PHE GLN ALA ASP PHE THR SER LEU SER ASP GLN SEQRES 25 A 379 GLU PRO LEU HIS VAL ALA GLN ALA LEU GLN LYS VAL LYS SEQRES 26 A 379 ILE GLU VAL ASN GLU SER CYS THR VAL ALA SER SER SER SEQRES 27 A 379 THR ALA VAL ILE VAL SER ALA ARG MET ALA PRO GLU GLU SEQRES 28 A 379 ILE ILE MET ASP ARG PRO PHE LEU PHE VAL VAL ARG HIS SEQRES 29 A 379 ASN PRO THR GLY THR VAL LEU PHE MET GLY GLN VAL MET SEQRES 30 A 379 GLU PRO MODRES 3R4L ASN A 232 ASN GLYCOSYLATION SITE MODRES 3R4L ASN A 288 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET BMA B 4 11 HET FUC B 5 10 HET NAG A 408 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 2 BMA 2(C6 H12 O6) FORMUL 2 FUC C6 H12 O5 FORMUL 4 HOH *17(H2 O) HELIX 1 1 SER A 29 ALA A 49 1 21 HELIX 2 2 SER A 58 GLN A 70 1 13 HELIX 3 3 LEU A 71 THR A 73 5 3 HELIX 4 4 GLY A 74 GLY A 86 1 13 HELIX 5 5 GLY A 93 MET A 106 1 14 HELIX 6 6 GLY A 131 ARG A 141 1 11 HELIX 7 7 GLU A 151 THR A 167 1 17 HELIX 8 8 HIS A 252 ASP A 254 5 3 HELIX 9 9 LEU A 270 ASN A 275 1 6 HELIX 10 10 SER A 278 ASN A 288 1 11 HELIX 11 11 LEU A 309 LEU A 316 1 8 HELIX 12 12 THR A 319 ARG A 323 5 5 SHEET 1 A 7 VAL A 55 PHE A 57 0 SHEET 2 A 7 THR A 392 VAL A 399 -1 O MET A 396 N PHE A 57 SHEET 3 A 7 PHE A 381 HIS A 387 -1 N PHE A 381 O VAL A 399 SHEET 4 A 7 LEU A 256 PRO A 263 -1 N PHE A 259 O VAL A 384 SHEET 5 A 7 TYR A 243 PRO A 250 -1 N LEU A 247 O ILE A 260 SHEET 6 A 7 THR A 219 THR A 237 -1 N THR A 234 O ILE A 246 SHEET 7 A 7 HIS A 208 HIS A 213 -1 N PHE A 212 O VAL A 220 SHEET 1 B 8 VAL A 55 PHE A 57 0 SHEET 2 B 8 THR A 392 VAL A 399 -1 O MET A 396 N PHE A 57 SHEET 3 B 8 PHE A 381 HIS A 387 -1 N PHE A 381 O VAL A 399 SHEET 4 B 8 LEU A 256 PRO A 263 -1 N PHE A 259 O VAL A 384 SHEET 5 B 8 TYR A 243 PRO A 250 -1 N LEU A 247 O ILE A 260 SHEET 6 B 8 THR A 219 THR A 237 -1 N THR A 234 O ILE A 246 SHEET 7 B 8 THR A 290 PRO A 299 -1 O LEU A 298 N MET A 225 SHEET 8 B 8 GLU A 374 ILE A 376 1 O ILE A 375 N LEU A 295 SHEET 1 C 5 LYS A 145 VAL A 147 0 SHEET 2 C 5 ILE A 114 GLN A 123 1 N VAL A 122 O LYS A 145 SHEET 3 C 5 LEU A 186 PHE A 194 -1 O VAL A 187 N PHE A 121 SHEET 4 C 5 GLN A 342 VAL A 351 1 O LEU A 344 N LEU A 188 SHEET 5 C 5 PHE A 301 ASP A 308 -1 N VAL A 307 O GLN A 345 SSBOND 1 CYS A 197 CYS A 355 1555 1555 2.02 LINK ND2 ASN A 232 C1 NAG A 408 1555 1555 1.44 LINK ND2 ASN A 288 C1 NAG B 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O6 NAG B 1 C1 FUC B 5 1555 1555 1.45 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.44 LINK O6 BMA B 3 C1 BMA B 4 1555 1555 1.47 CISPEP 1 THR A 362 ALA A 363 0 -22.62 CRYST1 72.007 72.007 194.481 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013888 0.008018 0.000000 0.00000 SCALE2 0.000000 0.016036 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005142 0.00000